Skip to content
Advertisement

The Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Biogen released a surprisingly low 2022 forecast Thursday, Feb. 3, 2022, as the drugmaker deals with sluggish sales from an Alzheimer’s treatment initially hailed as a potential breakthrough drug. (AP Photo/Steven Senne, File)

The Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Biogen released a surprisingly low 2022 forecast Thursday, Feb. 3, 2022, as the drugmaker deals with sluggish sales from an Alzheimer’s treatment initially hailed as a potential breakthrough drug. (AP Photo/Steven Senne, File)

Featured Photo Galleries